Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
Quantifying and Understanding the Higher Risk of ASCVD Among South Asians - American College of Cardiology
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol | Cardiovascular Diabetology | Full Text
Evidence-Based Treatment of Dyslipidemia: Patient-Centered Evaluation and Management
ASCVD Risk Estimator
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus | Journal of the American Heart Association
Primary prevention: the role of ASCVD risk enhancer. ASCVD,... | Download Scientific Diagram
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
ASCVD Risk Estimator +
Update Typ-2-Diabetes | SpringerLink
ASCVD Risk Estimator
Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus - ScienceDirect
JCI - Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Gurleen Kaur, MD on Twitter: "8/ Review of guidelines #ACC21 ♦️Emphasize heart-healthy lifestyle ♦️Clinical ASCVD➡️max tolerated statin to📉LDL by >50% ♦️Very high-risk ASCVD➡️threshold of 70mg/dL for non-statin ♦️LDL-C>190➡️high ...
ACC AHA guideline on the primary prevention of hypercholestrolemia - wikidoc
Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl | PLOS ONE
Recent Tendency of Nutritional Standard for Diabetes Mellitus with Chronic Kidney Disease (CKD) and Arteriosclerotic Cardiovascular
Risk Communication for Heart Disease - PCNA
Criteria for ASCVD risk assessment, treatment goals, and levels at... | Download Table
Machine learning models to predict atherosclerotic cardiovascular disease risk in multiethnic, real-world populations | Nature Portfolio Health Community
Aspirin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease: Summarizing Current Evidence
